期刊文献+

重度宫颈上皮内瘤变治疗前后检测高危型HPV的临床价值 被引量:1

Value of HPV-DNA test before and after LEEP of CIN in detection of prognosis
下载PDF
导出
摘要 目的研究重度宫颈上皮内瘤变(C IN)中高危型人乳头瘤病毒(HPV)感染情况,及术前与术后高危型HPV检测对预后的意义。方法门诊细胞学联合HPV检测,筛查出72例经病理诊断为C IN 2-3患者,采用电圈切除术(LEEP)治疗,术后每半年随访,包括:TCT,HPV,阴道镜。阴道镜检查有异常或HS IL者行活检,病理证实为C IN 2-3以上视为病变残留或复发。结果63例治愈,治愈率93.05%。9例(12.5%)复发或残留。72例患者中,58例HPV阳性,总感染率80.6%,C IN 3级患者HPV阳性率93.3%,较C IN 2患者阳性率71.4%显著升高。高危型阳性组LEEP术后病变残留或复发率与阴性组比较,差异无显著性。而术后高危型HPV检测残留或复发有较高的灵敏度和阴性预测价值。结论高危型HPV在重度C IN中感染率高,但术前高危型HPV与预后无关,术后高危型HPV检测预测残留或复发有重要价值。 Objective To determine the rate of HPV infection in cervical intraepithelial neoplasia(CIN) and to evaluate HPV- DNA test before and after LEEP in detection of prognosis. Methods A series of 72 women subjected to LEEP due to histologically confirmed CIN 2/3 were followed-up biannually including cervical cytology,hybrid capture tl (HC ~ ),and colposcopy. Pa- tients presenting abnormal eolposcopy or high-grade squamous inrraepithelial lesion (HSIL) smear were subjected to new excision procedure,and presence of histologically confirmed CIN 2/3 or higher was considered residual or recurrent. Results Nine (12.5%) women showed residual or recurrence of disease during the follow-up. The overall cure rate was 93.05%. The positive HC2 rate 93.3% in CIN3 was significantly higher than that in CIN2(71. 4%A,P〈0.05). Any statistically significant difference in residuals or recurrence between the two groups was not observed. HC2 in flow-up showed fairly high sensitivity and negative predictive value. Conclusion The rate of HPV infection in CIN2-3 is high. HPV-DNA test after LEEP values highly in detecting residuals or recurrence,but it has no significance before LEEP.
出处 《淮海医药》 CAS 2006年第2期105-106,共2页 Journal of Huaihai Medicine
关键词 官颈上皮内瘤变 电圈切除术 人乳头瘤病毒 Cervical intraepithelial neoplasiat Loop electrosurgical excision procedure t Human papillomavirus
  • 相关文献

参考文献6

  • 1沈艳红,陈凤,黄曼妮,刘彬,王希霞,赵方辉,李淑敏,李楠,吴令英,戎寿德,章文华,任生达,黄瑞德,乔友林.我国山西省子宫颈癌高发区人乳头瘤病毒感染调查[J].中国医学科学院学报,2003,25(4):381-385. 被引量:121
  • 2Houfflin Debarge V,Collinet P,Vinatier D,et al.Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelical lesions[J].Gynecol Oncol,2003,90(3):587-592.
  • 3Nagai Y,Maehama T,Asato T,et al.Persistence of human papillomavirus infection after therapeutic conization for CIN 3:is it an alarm for disease recurrence[J].Gynecol Oncol,2000,79:294-299.
  • 4Lin CT,Tseng CJ,Lai CH,et al.Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy spectimen[J].Am J Obstet Gynecol,2001,184(5):940-945.
  • 5Johnson N,Khalili M,Hirschwitz L,et al.Predicting residual disease after excision of cervical dysplasia[J].BJOG International Journal of Obstetrics and Gynecology,2003,110:952.
  • 6Bar-Am A,Gamzu R,Cevin I,et al.Following by combined cytology and human papillomavirus testing for patients postcone biopsy:Results of a long term follow up[J].Gynecol Oncol,2003,91:149.

二级参考文献17

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Clavel C, Masure M, Putaud I, et al. Hybrid Capture-Ⅱ, a new sensitive test for human papiUomavirus detection.Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol, 1998, 51(9):737-740.
  • 3Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the Hybrid Capture human papiUomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol, 1995, 173:1432-1437.
  • 4Levert M, Clavel C, Graesslin O, et al. Human papillomavirus typing in routine cervical smears: results from a series of 3778 patients. Gynecol Obstet Fertil, 2000, 28(10):722-728.
  • 5Solomon D, Schiffman M, Tarone R, et ol. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Nail Cancer Inst, 2001, 93(4):293-299.
  • 6Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or eolposeopy.Int J Cancer, 2000, 89(6):529-534.
  • 7Clavel C, Masure M, Bory JP, et al. Hybrid Capture Ⅱ-based human papiUomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer, 1999, 80(9):1306-1311.
  • 8Clavel C, Masure M, Levert M, et al. H,man papillomavirusdetection by the hybrid capture I1 assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol, 2000, 9(3):145-150.
  • 9Bosch FX, Manos MM, Munos N, et al. Prevalence of human papillomavirus in cervical cancer:a worldwide perspective. J Natl Cancer Inst, 1995, 87:796-802.
  • 10Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women:a longitudinal cohorts study. Lancet, 2001, 357(9271):1831-1836.

共引文献120

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部